S

STAAMP Research | San Antonio, TX

Research site

(Unclaimed)

Location

7711 Louis Pasteur Drive, Suite 406, San Antonio, Texas, United States of America

Site insights

Top conditions

Top treatments

OPN-375

Remibrutinib

Lunsekimig

dupiluMAb

Albuterol Sulfate

SAR443765

OM-85

Omalizumab

Fluticasone Propionate

DUPIXENT®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 16 total trials

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension...

Active, not recruiting

Chronic Inducible Urticaria

Drug: Remibrutinib

Other: Placebo

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

The primary objective of the study is to assess the efficacy of high dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic m...

Active, not recruiting

Asthma

Drug: TEV-56248

Drug: Albuterol sulfate

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps (Re-Open 3)

This is a 12-Week randomized, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy and safety of intranasal ad...

Enrolling

Chronic Rhinosinusitis Without Nasal Polyps

Drug: OPN-375

Drug: Placebo

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is...

Active, not recruiting

Asthma

Drug: Budesonide/Albuterol

Drug: Lunsekimig